Meet Our Experts
Please select a topic:
Experts for: Biomarkers
Daniel Sehrt
Expert for Early Clinical Research & Development
- Scientific concept & design of Phase I-IIa trials
- Clinical pharmacology (PK/PD and pharmacogenomics)
- Clinical trial applications
Hans Hendriks
Expert for Pre- and Early Clinical Drug Development
- Scientific and Regulatory Medical Writing (Oncology, Inflammatory Diseases)
- Non-Clinical and Early Clinical Anticancer Drug Development
Wolf-Stefan Richter
Expert for Clinical Development
- Study design and imaging biomarkers
- Medical need assessment
- Medical regulatory strategy
Frank S. Zollmann
Expert for Pre-/ Clinical Drug Development
- Safety pharmacology, toxicology, pharmacogenomics
- Integrated preclinical & clinical development up to PoC
- Clinical pharmacology
Jörg Täubel
Expert for cardiac safety in drug development
Astrid Schott
Expert for Clinical Research & Development
- Clinical Development planning, Phase I-III
- Interim management
- Due Diligence, licensing
Anke Maaßen
Expert for In Vitro Diagnostics (IVDs)
- Regulatory Affairs (EU regulations: IVDD and IVDR)
- Quality Management and Assurance
- Internal and Supplier Audits
- Support for Manufacturing and Control